The global home infusion therapy market size was valued at USD 41.65 billion in 2025 and is projected to grow from USD 44.99 billion in 2026 to USD 83.47 billion by 2034, registering a CAGR of 8.03% during the forecast period from 2026 to 2034. North America dominated the home infusion therapy market with a market share of 42.6% in 2025.
Advances in home infusion therapy are transforming care delivery from hospital-centric treatment to patient-managed, decentralized models, improving outcomes and reducing healthcare costs. The rising prevalence of chronic diseases, including diabetes, cancer, and immune disorders, is driving demand for long-term intravenous therapies administered at home. The International Diabetes Federation 2025 stated that approximately 589 million adults aged 20-79 are living with diabetes.
Clinical studies indicate that home infusion can lower hospitalization rates by over 20% while enhancing patient satisfaction and adherence. Technological innovations such as portable infusion pumps, elastomeric devices, and smart monitoring systems improve safety, dosing accuracy, and mobility. Expanding aging populations and increased preference for cost-effective care settings further accelerate market growth. Opportunities are emerging through partnerships with home healthcare providers, specialty pharmacies, and digital health platforms.
Download a Free Sample To learn more about this report,
Growing Adoption of Home-Based Infusion Care and Remote Monitoring
The home infusion therapy market trends are being driven by the growing shift toward home-based healthcare, increasing demand for convenient treatment, and advances in portable infusion technologies. Patients are increasingly receiving intravenous or subcutaneous medicines, antibiotics, nutrition, and other therapies at home instead of staying in hospitals for extended periods. Portable and wearable infusion pumps are supporting this transition by allowing controlled medication delivery while giving patients greater mobility. Healthcare providers are also adopting remote monitoring and digital health tools to track treatment progress, improve adherence, and identify potential problems earlier. In the U.S., the Medicare home infusion therapy benefit includes professional services, nursing, training, education, and remote monitoring for eligible therapies. The expansion of home healthcare infrastructure and the growing focus on reducing hospital stays are further supporting the use of home infusion services. Manufacturers are also improving pump safety, battery performance, connectivity, and ease of use for home environments.
These developments indicate that home-based treatment, portable infusion pumps, remote monitoring, and digital healthcare services will remain the key home infusion therapy market trends, improving patient convenience, supporting safer treatment delivery, and driving long-term growth across home healthcare.
Rising Prevalence of Chronic Diseases and Growing Preference for Home-Based Care
The home infusion therapy market is expanding due to the increasing prevalence of chronic diseases, infections, cancer, and immune disorders that require long-term intravenous or subcutaneous therapies. Healthcare providers and patients are increasingly preferring home-based infusion services because they can reduce hospital visits, improve patient comfort, and support continued treatment outside traditional clinical settings. Rising healthcare expenditure, aging populations, and advances in portable infusion technologies are further accelerating adoption. These developments are significantly contributing to home infusion therapy market growth as healthcare systems increasingly focus on cost-effective and patient-centered care.
High Therapy Costs and Shortage of Skilled Healthcare Professionals
The home infusion therapy market faces challenges due to the high cost of infusion equipment, medications, nursing services, and ongoing patient monitoring. Home-based infusion therapy requires trained healthcare professionals to administer treatments, manage complications, and educate patients and caregivers, creating workforce and operational challenges. Limited reimbursement coverage and variations in healthcare policies can also restrict access to home infusion services. Recent home infusion therapy market analysis indicates that these factors remain significant barriers to adoption, particularly among cost-sensitive patient populations.
Expansion of Specialty Infusion Therapies and Remote Patient Monitoring
The home infusion therapy market is expected to benefit from increasing demand for specialty medications, biologic therapies, antimicrobial treatments, and nutrition support delivered outside hospital environments. Advancements in smart infusion pumps, telehealth, remote patient monitoring, and digital care coordination are creating significant growth opportunities for service providers. Growing healthcare system efforts to reduce hospital stays and manage treatment costs are also supporting the transition toward home-based infusion care. These developments are expected to strengthen the home infusion therapy market size by expanding access to specialized treatments and improving continuity of care.
Ensuring Patient Safety and Maintaining Effective Care Coordination
The home infusion therapy market continues to face challenges related to patient safety, infection prevention, medication management, and coordination between patients, caregivers, physicians, pharmacies, and home healthcare professionals. Providers must ensure proper catheter care, accurate medication administration, timely monitoring, and rapid intervention when complications occur. Differences in home environments and patient capabilities can also affect treatment adherence and service quality. According to recent home infusion therapy market reports, companies are investing in digital monitoring platforms, smart infusion pumps, caregiver education, and coordinated care models to improve treatment safety and strengthen long-term service delivery.
Services Segment is Projected to Register the Fastest Growth at a CAGR of 8.9%
The services segment is projected to register the fastest growth at a CAGR of 8.9% during 2026–2034. In 2025, the segment accounted for 38.5% of the global home infusion therapy market, with a value of USD 16.04 billion. Growth is driven by increasing preference for home-based healthcare, rising demand for specialized infusion services, and the growing need for convenient treatment outside traditional healthcare facilities. Expanding home healthcare infrastructure and increasing adoption of patient-centered care continue to support the segment's growth.
The products segment dominated the market with a 61.5% share and a value of USD 25.61 billion. Its leading position is supported by the widespread use of infusion pumps, intravenous sets, IV cannulas, and needleless connectors in home-based infusion therapy. Increasing demand for reliable infusion equipment and advances in portable medical devices continue to reinforce the segment's market position.
Request Customizationto receive a tailored report.
Infusion Pumps Segment is Projected to Register the Fastest Growth at a CAGR of 8.7%
The infusion pumps segment is projected to register the fastest growth at a CAGR of 8.7% during 2026–2034. In 2025, the segment accounted for 43.2% of the global home infusion therapy market, with a value of USD 17.99 billion. Growth is driven by increasing demand for controlled and accurate medication delivery, rising adoption of portable infusion technologies, and growing preference for home-based treatment. Technological advancements in pump design and improved patient safety features continue to support the segment's growth.
The intravenous sets segment accounted for 27.4% of the market, with a value of USD 11.41 billion and a CAGR of 8.2%. IV cannulas represented 18.6% of the market, while needleless connectors accounted for 10.8%. These products continue to support home infusion therapy by enabling safe, efficient, and reliable administration of intravenous treatments.
Specialty Pharmaceuticals Segment is Projected to Register the Fastest Growth at a CAGR of 9.4%
The specialty pharmaceuticals segment is projected to register the fastest growth at a CAGR of 9.4% during 2026–2034. In 2025, the segment accounted for 12.1% of the global home infusion therapy market, with a value of USD 5.04 billion. Growth is driven by increasing availability of complex specialty medicines, rising demand for personalized treatment, and growing adoption of home-based administration for therapies that previously required healthcare facility visits. Expanding access to specialty pharmaceutical treatments continues to support the segment's growth.
The anti-infective segment dominated the market with a 24.7% share and a value of USD 10.29 billion, owing to the widespread use of home infusion therapy for prolonged antimicrobial treatment. Chemotherapy accounted for 14.8%, followed by endocrinology at 13.6% and enteral nutrition at 12.4%. Hydration therapy and parenteral nutrition continue to contribute to market growth through increasing demand for supportive and long-term home-based therapies.
Speak to an Analystto discuss market opportunities.
North America home infusion therapy market accounted for 42.6% of the global market, reaching USD 17.74 billion in 2025, and is projected to grow at a CAGR of 7.9% during the forecast period. The market is driven by increasing prevalence of chronic diseases, growing demand for home-based healthcare, rising healthcare costs, and increasing preference for convenient and personalized treatment options. Expanding home healthcare infrastructure and advancements in infusion technologies continue to support regional market growth.
The US market was valued at USD 15.08 billion in 2025, making it the largest contributor in North America. Increasing demand for home-based treatment, growing prevalence of chronic conditions, rising healthcare expenditure, and expanding adoption of portable infusion devices continue to drive market growth.
Canada's market reached USD 2.66 billion in 2025. Growing demand for home healthcare services, increasing aging population, expanding access to infusion therapy, and rising adoption of advanced home infusion technologies continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe home infusion therapy market accounted for 27.8% of the global market, reaching USD 11.58 billion in 2025, and is projected to grow at a CAGR of 7.6% during the forecast period. Increasing prevalence of chronic diseases, growing adoption of home healthcare services, rising healthcare expenditure, and increasing demand for cost-effective treatment alternatives continue to strengthen regional market growth. Expanding healthcare infrastructure and greater patient preference for home-based care further support market expansion.
The UK market was valued at USD 2.32 billion in 2025. Increasing demand for community-based healthcare, growing prevalence of chronic diseases, expanding home treatment programs, and rising adoption of advanced infusion technologies continue to support market growth.
Germany market accounted for USD 3.24 billion in 2025. Strong healthcare infrastructure, increasing demand for home-based medical care, growing elderly population, and rising investments in advanced infusion systems continue to drive market expansion.
Asia Pacific home infusion therapy market accounted for 19.7% of the global market, reaching USD 8.21 billion in 2025, and is projected to grow at a CAGR of 10.3% during the forecast period. Rapid healthcare infrastructure development, increasing prevalence of chronic diseases, growing healthcare expenditure, and rising demand for home-based treatment continue to accelerate regional market growth. Increasing awareness of home healthcare and expanding access to advanced infusion technologies further strengthen market expansion.
China's market accounted for USD 3.45 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare infrastructure, increasing demand for home-based care, growing chronic disease burden, and rising investments in healthcare technologies continue to drive market expansion.
Japan's market generated USD 1.48 billion in 2025. Increasing elderly population, growing demand for home healthcare, expanding adoption of portable infusion devices, and rising healthcare modernization continue to support market growth.
Middle East and Africa home infusion therapy market accounted for 4.1% of the global market, totaling USD 1.71 billion in 2025, and is projected to grow at a CAGR of 7.4% during the forecast period. Increasing investments in healthcare infrastructure, growing prevalence of chronic diseases, expanding home healthcare services, and rising awareness of home-based treatment options continue to support regional market growth.
The UAE market was valued at USD 0.43 billion in 2025. Increasing investments in advanced healthcare infrastructure, growing demand for home-based medical services, expanding private healthcare facilities, and rising adoption of innovative infusion technologies continue to drive market growth.
Africa's market reached USD 1.28 billion in 2025. Expanding healthcare access, increasing investments in healthcare infrastructure, growing demand for affordable home-based treatment, and rising awareness of infusion therapy continue to create long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Assisted Walking Devices Market Size, Share, Growth, 2034
Spirometer Market Size, Share, Growth, Analysis, Report, 2034
Vessel Sealing Devices Market Size, Share, Growth, Analysis, 2034
ECG Patch and Holter Monitor Market Size, Share, Growth, 2034
Tampon Market Size, Share, Growth, Opportunities, Analysis, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com